Clinical Trial Update: Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment

View source ↗

Summary

The clinical trial investigating omega-3 fatty acid status in morbid obesity before and after surgical treatment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Morbid Obesity

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Cincinnati | Conditions: Morbid Obesity, Cardiovascular Disease | Status: WITHDRAWN